| Recruiting | A Clinical Study of SPH9788 Tablets in Healthy Chinese Subjects. Healthy Participants | Phase 1 | 2025-03-02 |
| Recruiting | A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors. Advanced Solid Tumor | Phase 1 | 2024-08-06 |
| Recruiting | A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Canc Biliary Tract or Colorectal Cancer With Her2-positive/Mutated | Phase 2 | 2024-07-17 |
| Recruiting | A Clinical Study of SPH7854 Granules in Healthy Subjects. Inflammatory Bowel Disease | EARLY_Phase 1 | 2024-05-28 |
| Completed | A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma Sarcoma, Ewing | Phase 2 | 2024-03-12 |
| Completed | A Food Effect Study of SPH5030 Tablets. Advanced Solid Tumor | Phase 1 | 2024-03-04 |
| Recruiting | A Clinical Study of T3011 in Subjects With Advanced Melanoma Advanced Melanoma | Phase 1 / Phase 2 | 2024-01-26 |
| Recruiting | A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 / Phase 2 | 2024-01-11 |
| Recruiting | A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Adva Advanced Solid Tumors | Phase 1 / Phase 2 | 2023-10-17 |
| Recruiting | Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Meta Breast Cancer Brain Metastases | Phase 2 | 2023-09-19 |
| Recruiting | Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or M Locally Advanced or Metastatic Breast Cancer | Phase 2 / Phase 3 | 2023-09-08 |
| Completed | A Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis Mild to Moderate Ulcerative Colitis | Phase 2 | 2023-06-19 |
| Recruiting | Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatme Locally Advanced or Metastatic Breast Cancer | Phase 2 / Phase 3 | 2023-04-24 |
| Recruiting | Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke Acute Ischemic Stroke | Phase 2 | 2023-04-06 |
| Completed | Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease Diabetic Kidney Disease | Phase 2 | 2023-03-22 |
| Completed | Study on Human Mass Balance of SPH3127 Tablets Primary Mild and Moderate Hypertension | Phase 1 / Phase 2 | 2022-10-16 |
| Recruiting | Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD) NMO Spectrum Disorder | EARLY_Phase 1 | 2022-04-07 |
| Recruiting | SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors HER2-positive Advanced Solid Tumors | EARLY_Phase 1 | 2022-01-21 |
| Completed | A Clinical Study of SPH6516 Tablets in the Treatment of Advanced Solid Tumors. Advanced Solid Tumor | EARLY_Phase 1 | 2022-01-20 |
| Completed | Drug-drug Interaction Study of SPH3127 Drug Drug Interaction | Phase 1 / Phase 2 | 2021-12-13 |
| Completed | Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension Essential Hypertension | Phase 3 | 2021-06-10 |
| Completed | Phase I Clinical Study of SPH4336 Tablets in the Treatment of Advanced Solid Tumors Advanced Solid Tumors | Phase 1 / Phase 2 | 2020-11-03 |
| Completed | Clinical Study of SPH3348 Tablets, a C-Met Inhibitor, in Patients with Advanced Solid Tumors Solid Tumor | Phase 1 | 2020-07-02 |
| Completed | Safety and Efficacy of T8 on Treating Chronic Abnormal Immune Activation in HIV/AIDS Patients Chronic Abnormal Immune Activation in HIV/AIDS | Phase 2 | 2019-12-25 |
| Completed | B002 in Patients With HER2-positive Breast Cancer Recurrent Breast Cancer, Metastatic Breast Cancer | Phase 1 | 2019-05-28 |
| Completed | B003 in Patients With HER2-positive Recurrent or Metastatic Breast Cancer HER2-positive Breast Cancer | Phase 1 | 2019-04-01 |
| Completed | Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients Hypertension,Essential | Phase 2 | 2019-01-11 |
| Completed | B001 in Patients With CD20 Positive B-cell Non Hodgkin's Lymphoma CD20 Positive B Cell Non-Hodgkin's Lymphoma | Phase 1 | 2018-03-22 |
| Completed | The Tolerability and Pharmacokinetics of Multiple Doses of SPH3127 in Chinese Healthy People Hypertension | Phase 1 | 2017-10-23 |
| Completed | The Effect of Food Intake on the Pharmacokinetic of Single Dose SPH3127 Tablets in Chinese Health Subjects Hypertension | Phase 1 | 2017-09-23 |
| Withdrawn | Phase I Study of SPH1188-11 in NSCLC NSCLC Stage IIIB, NSCLC Stage IV | Phase 1 | 2017-07-21 |
| Completed | Single Ascending Dose Study of Safety and Tolerability of SPH3127 Tablet in Chinese Healthy Volunteers Hypertension | Phase 1 | 2016-12-01 |
| Completed | Hydroxytriptolide in Active Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate Rheumatoid Arthritis | Phase 1 / Phase 2 | 2014-06-01 |
| Completed | Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis Ankylosing Spondylitis | Phase 2 | 2013-02-01 |